In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Ixel Luna-CañedoMesenchymal Stem Cell Laboratory, Oncology Research Unit, Oncology Hospital, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Guadalupe Rosario Fajardo-OrduñaMesenchymal Stem Cell Laboratory, Oncology Research Unit, Oncology Hospital, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-1001-4073 Rosana PelayoUnidad de Educación e Investigación, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Juan Carlos BalandránDepartment of Pathology, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0003-1978-248X Héctor MayaniHematopoietic Stem Cell Laboratory, Oncology Research Unit, Oncology Hospital, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Constantino López-MacíasUnidad de Investigación Médica en Inmunoquímica, Unidad Médica de Alta Especialidad Hospital de Especialidades, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0003-0530-492X Marco Alejandro Jimenez-OchoaUnidad de Trasplante de Médula Ósea, Unidad Médica de Alta Especialidad Hospital de Especialidades, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-2710-4956 Rodolfo Eduardo Pastelin-RuizUnidad Médica de Alta Especialidad Hospital de Traumatología "Dr. Victorio de la Fuente Narváez", Instituto Mexicano del Seguro Social, Mexico City 07760, Mexico.
Juan José MontesinosMesenchymal Stem Cell Laboratory, Oncology Research Unit, Oncology Hospital, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-1042-3205 Víctor Adrián Cortés-MoralesUnidad de Investigación Médica en Inmunoquímica, Unidad Médica de Alta Especialidad Hospital de Especialidades, National Medical Center "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-3331-7309 Funding
Mexican Social Security Institute R-2024-785-039
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
hematopoietic progenitor cellslymphopoiesis supportmesenchymal stromal cellsmyelopoiesis support
Identifiers
PMID42792864
PMCPMC13604451
What OpenQuestion holds
Textmetadata
Read underepoch 390